Anna Kazanchyan, MD

Greenwich, Connecticut, United States
Anna Kazanchyan, M.D. is CEO and Founder of Saghmos Therapeutics. Previously, she was SVP, Business Development and SVP, Product Development at Ovid Therapeutics. She is Founder and Managing Partner of Primary i-Research, LLC, where she was an Executive Advisor to biopharmaceutical companies. Previously, Dr. Kazanchyan was Senior Biotechnology Analyst at Wells Fargo, and was a member of the Institutional-Investor ranked Biotechnology Equity Research teams at Goldman Sachs and Citi. She received an M.D. from Harvard Medical School.
Speaking In
11:30 AM - 11:45 AM (EST)
Monday, February 6
Saghmos Therapeutics is a privately held biopharmaceutical company whose mission is to develop…
Winter Garden
3:00 PM - 3:45 PM (EST)
Tuesday, February 7
Supply chain shortages, rising costs, changes in the workforce, and continued macroeconomic…
South Broadway Ballroom
4:00 PM - 4:45 PM (EST)
Tuesday, February 7
Despite softening valuations among public biotechs and a major tightening of post-series B private…
South Broadway Ballroom